Article info
PDFMultiple sclerosis
Research paper
Treatment effect of natalizumab on relapse outcomes in multiple sclerosis patients despite ongoing MRI activity
- Correspondence to Professor D Bates, Department of Neurology, Royal Victoria Infirmary, Newcastle University, Newcastle on Tyne NE1 4LP, UK; david.bates{at}newcastle.ac.uk
Citation
Treatment effect of natalizumab on relapse outcomes in multiple sclerosis patients despite ongoing MRI activity
Publication history
- Received April 11, 2011
- Revised July 13, 2011
- Accepted July 16, 2011
- First published August 23, 2011.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.